N
Neuphoria Therapeutics Inc
NASDAQ:NEUP
Neuphoria Therapeutics Inc
NASDAQ:NEUP
Price:
4.78
USD
1.27%
Market Closed
Market Cap:
$25.8m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
N
|
Neuphoria Therapeutics Inc
NASDAQ:NEUP
|
US |
|
BioCardia Inc
NASDAQ:BCDA
|
US |
|
AI/ML Innovations Inc
OTC:AIMLF
|
CA |
|
C
|
Collective Audience Inc
NASDAQ:CAUD
|
US |
|
A
|
Apartment Income REIT Corp
NASDAQ:OM
|
US |
|
Holmen AB
STO:HOLM B
|
SE |
|
Log Commercial Properties e Participacoes SA
BOVESPA:LOGG3
|
BR |
Income Statement
Earnings Waterfall
Neuphoria Therapeutics Inc
Neuphoria Therapeutics Inc
Income Statement
Neuphoria Therapeutics Inc
Neuphoria Therapeutics Inc
Currency: USD
| Jun-2020 | Dec-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||
| Interest Expense |
1
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
0
N/A
|
0
+235%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
-1%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
1
N/A
|
16
+2 262%
|
16
0%
|
16
+0%
|
15
-4%
|
|
| Operating Income | ||||||||||||||||
| Operating Expenses |
(3)
|
(3)
|
(6)
|
(16)
|
(16)
|
(19)
|
(22)
|
(32)
|
(18)
|
(31)
|
(26)
|
(29)
|
(17)
|
(19)
|
(17)
|
|
| Selling, General & Administrative |
(4)
|
(7)
|
(5)
|
(10)
|
(8)
|
(8)
|
(9)
|
(14)
|
(8)
|
(15)
|
(13)
|
(14)
|
(8)
|
(8)
|
(7)
|
|
| Research & Development |
(4)
|
(5)
|
(4)
|
(9)
|
(12)
|
(14)
|
(13)
|
(18)
|
(9)
|
(16)
|
(13)
|
(15)
|
(9)
|
(11)
|
(10)
|
|
| Other Operating Expenses |
5
|
9
|
3
|
3
|
4
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Operating Income |
(3)
N/A
|
(3)
-17%
|
(6)
-101%
|
(16)
-141%
|
(16)
-3%
|
(18)
-14%
|
(22)
-20%
|
(32)
-45%
|
(18)
+44%
|
(31)
-75%
|
(25)
+20%
|
(13)
+48%
|
(1)
+91%
|
(3)
-185%
|
(2)
+27%
|
|
| Pre-Tax Income | ||||||||||||||||
| Interest Income Expense |
(2)
|
(1)
|
(0)
|
(1)
|
0
|
1
|
1
|
0
|
0
|
(0)
|
0
|
1
|
(0)
|
0
|
(1)
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
|
| Gain/Loss on Disposition of Assets |
0
|
0
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
2
|
5
|
6
|
5
|
1
|
(7)
|
(2)
|
|
| Pre-Tax Income |
(4)
N/A
|
(4)
-2%
|
(7)
-61%
|
(16)
-145%
|
(16)
+2%
|
(17)
-8%
|
(22)
-25%
|
(32)
-47%
|
(16)
+51%
|
(27)
-71%
|
(18)
+31%
|
(7)
+61%
|
(1)
+88%
|
(10)
-1 074%
|
(6)
+38%
|
|
| Net Income | ||||||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(4)
|
(4)
|
(6)
|
(16)
|
(16)
|
(17)
|
(21)
|
(31)
|
(15)
|
(26)
|
(18)
|
(7)
|
(0)
|
(9)
|
(6)
|
|
| Net Income (Common) |
(5)
N/A
|
(5)
0%
|
(6)
-36%
|
(16)
-147%
|
(16)
+2%
|
(17)
-8%
|
(21)
-25%
|
(31)
-47%
|
(15)
+51%
|
(26)
-70%
|
(18)
+31%
|
(7)
+62%
|
(0)
+95%
|
(9)
-2 460%
|
(6)
+40%
|
|
| EPS (Diluted) |
-0.08
N/A
|
-0.08
N/A
|
-0.1
-25%
|
-0.21
-110%
|
-0.14
+33%
|
-0.16
-14%
|
-0.17
-6%
|
-0.24
-41%
|
-0.1
+58%
|
-0.11
-10%
|
-11.57
-10 418%
|
-4.05
+65%
|
-0.23
+94%
|
-4.21
-1 730%
|
-1.24
+71%
|
|
Switch to:
Switch to:
See Also
Discover More
